{"id":"W2093322643","doi":"10.1186/1476-4598-6-67","title":"Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Stem Cell Network; Kenneth T. and Eileen L. Norris Foundation","keywords":"Nilotinib; Imatinib; Leukemia; Cancer research; Chronic myelogenous leukemia; Imatinib mesylate; Tyrosine-kinase inhibitor; Philadelphia chromosome; Acute lymphocytic leukemia; Tyrosine kinase; Medicine; Biology; Immunology; Internal medicine; Myeloid leukemia; Cancer; Chromosomal translocation; Lymphoblastic Leukemia; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004200143,0.001155987,0.0006526846,0.001177125,0.000346247,0.0005503674,0.0006082293,0.0009074926,0.002735383],"category_scores_gemma":[0.0001369294,0.0003021945,0.0005809784,0.0005267326,0.0004633262,0.0004687865,0.0002746646,0.001975293,0.001081645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007533388,"about_ca_system_score_gemma":0.0003766409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005742566,"about_ca_topic_score_gemma":0.000932115,"domain_scores_codex":[0.9994909,0.00009532132,0.00004590513,0.00008652205,0.0001653624,0.0001159686],"domain_scores_gemma":[0.9998026,0.00002377037,0.00007038441,0.00002351598,0.0000197332,0.0000598262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001414676,0.0007678781,0.0005189187,0.000177043,0.00003488961,0.0003947966,0.00005182933,0.0003015169,0.9909672,0.0004580337,0.0005967514,0.004316488],"study_design_scores_gemma":[0.0003850002,0.00618977,0.003203626,0.00003740187,0.0001151188,0.001543819,0.00006290796,0.001162644,0.9734247,0.0001656558,0.01368703,0.00002240416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9617777,0.0118418,0.00884201,0.0008464462,0.0003962956,0.0009665455,0.004989511,0.001188678,0.009151145],"genre_scores_gemma":[0.9723257,0.006236997,0.005169003,0.0002754146,0.00005749444,0.001319061,0.004555532,0.0001156565,0.00994505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002735383,"threshold_uncertainty_score":0.009150743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01972228297517697,"score_gpt":0.2880412356463142,"score_spread":0.2683189526711372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}